5 completed, 2 recruiting, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Recruiting 2, Unknown 1 |
Follow Healthy Controls: new trials by email Literature Review of Healthy Controls trials Research Report on Healthy Controls
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect? Haloperidol, Placebo, Insulin Lispro - Brain Insulin Sensitivity, Healthy Controls | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 35 | 2025-12-11 | 2026-04-02 |
| Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims - Dementia With Lewy Bodies, Parkinson Disease Dementia | Phase 4 | Recruiting | Virginia Commonwealth University | 120 | 2025-12-08 | 2026-03-06 |
| Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER) Shingrix - Rheumatoid Arthritis, Healthy Controls | Phase 4 | Completed | Region Skane | 142 | 2019-03-15 | 2023-06-22 |
| Serotonin and Motor Plasticity Escitalopram, Placebo - Healthy Controls | Phase 4 | Unknown | Max Planck Institute for Human Cognitive and Brain Sciences | 60 | 2017-04-01 | 2017-05-22 |
| Xyrem and Brain Dopamine in Narcolepsy Xyrem - Narcolepsy With Cataplexy, Healthy Controls | Phase 4 | Completed | Centre for Addiction and Mental Health | 17 | 2016-01-01 | 2021-03-23 |
| Biomarker Assessment of Glutamatergic Target Engagement Ketamine, Normal saline - Healthy Controls | Phase 4 | Completed | New York State Psychiatric Institute | 65 | 2014-05-01 | 2018-08-17 |
| Effects of Treatment on Decision-making in Major Depression Any FDA Approved Antidepressant - Major Depressive Disorder, Healthy Controls | Phase 4 | Completed | Emory University | 53 | 2013-08-01 | 2017-11-21 |
| Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin. Capsaicin - Idiopathic Rhinitis Patients, Healthy Controls | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 36 | 2011-01-01 | 2011-10-03 |
Arthritis, Rheumatoid (1) · Depression (1) · Depressive Disorder (1) · Depressive Disorder, Major (1) · Lewy Body Disease (1) · Narcolepsy (1)
Mental Disorders (3) · Nervous System Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Basal Ganglia Diseases (1) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Connective Tissue Diseases (1) · Dementia (1) · Disorders of Excessive Somnolence (1) · Dyssomnias (1) · Immune System Diseases (1) · Joint Diseases (1)
Escitalopram (2) · Sodium Chloride (2) · Bupropion (1) · Capsaicin (1) · Citalopram (1) · Desvenlafaxine Succinate (1) · Duloxetine Hydrochloride (1) · Fluoxetine (1) · Haloperidol (1) · Insulin Lispro (1) · Ketamine (1) · Mirtazapine (1) · Paroxetine (1) · Saline Solution (1) · Sertraline (1)
Centre for Addiction and Mental Health (2) · Emory University (1) · Max Planck Institute for Human Cognitive and Brain Sciences (1) · New York State Psychiatric Institute (1) · Region Skane (1) · Universitaire Ziekenhuizen KU Leuven (1) · Virginia Commonwealth University (1)
United States (3) · Canada (2) · Belgium (1) · Germany (1) · Sweden (1)
Arno Villringer (1) · Boadie W Dunlop, MD (1) · Jeffrey A Lieberman, MD (1) · Julia Sacher (1) · Laura H Van Gerven, MD (1) · Mahavir Agarwal, MBBS, MD, PhD (1) · Matthew Barrett (1) · Peter W Hellings, MD, PhD (1) · Stephen J Kish, Ph.D. (1)
PMID 29167877, PMID 37851412, PMID 41330694
R01NS142622 (1)